Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 16/20 | 0.59 |
| ▸ | CA2 | P00918 | 16/20 | 0.59 |
| ▸ | CA9 | Q16790 | 14/20 | 0.59 |
| ▸ | CA12 | O43570 | 5/20 | 0.59 |
| ▸ | CA7 | P43166 | 5/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.59 |
| ▸ | CA3 | P07451 | 4/20 | 0.59 |
| ▸ | CA4 | P22748 | 4/20 | 0.59 |
| ▸ | CA6 | P23280 | 4/20 | 0.59 |
| ▸ | CA5A | P35218 | 4/20 | 0.59 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.59 |
| ▸ | RECQL | P46063 | 2/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1723674 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| SCHEMBL9311891 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| SCHEMBL28580715 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| SCHEMBL9116898 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| SCHEMBL21357037 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| SCHEMBL8745708 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| SCHEMBL29767203 | 0.98 | CA1 (0.57) | CA1CA2CA9CA12CA7 | |
| SCHEMBL29361862 | 0.98 | CA1 (0.57) | CA1CA2CA9CA12CA7 | |
| SCHEMBL29426307 | 0.98 | CA1 (0.57) | CA1CA2CA9CA12CA7 | |
| SCHEMBL30116332 | 0.98 | CA1 (0.57) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12391772-B2 | Modified starches for home care and personal care | CARGILL, INCORPORATED (US) | 2025-08-19 | — | — | US | disclosed |
| US-20240150678-A1 | Cleaning Composition | AUNT FANNIE INC (US) | 2024-05-09 | — | — | US | disclosed |
| US-11918678-B2 | Hair cleansing composition | CONOPCO, INC. (US) | 2024-03-05 | — | — | US | disclosed |
| US-20240043570-A1 | MODIFIED STARCHES FOR HOME CARE AND PERSONAL CARE | CARGILL, INCORPORATED (US) | 2024-02-08 | — | — | US | disclosed |
| CN-115590785-A | Improved formulation for personal care products | 嘉吉有限公司（US） | 2023-01-13 | — | — | CN | disclosed |
| WO-2023278985-A1 | IMPROVED FORMULATIONS OF PERSONAL CARE PRODUCTS | CARGILL, INCORPORATED (US) | 2023-01-05 | — | — | WO | disclosed |
| EP-4028427-A1 | MODIFIED STARCHES FOR HOME CARE AND PERSONAL CARE | Cargill, Incorporated (US) | 2022-07-20 | — | — | EP | disclosed |
| CN-114616253-A | Modified starches for home and personal care | 嘉吉有限公司 | 2022-06-10 | — | — | CN | disclosed |
| WO-2022099149-A1 | CLEANING COMPOSITION | AUNT FANNIE INC. (US) | 2022-05-12 | — | — | WO | disclosed |
| US-20220145219-A1 | Cleaning Composition | AUNT FANNIE INC. (US) | 2022-05-12 | — | — | US | disclosed |
| CN-111328812-A | Herbicidal composition and use thereof | 四川利尔作物科学有限公司 | 2020-06-26 | — | — | CN | disclosed |
| US-5434276-A | Process for making N-acyl taurides | FINETEX, INC. (US) | 1995-07-18 | — | — | US | disclosed |
| WO-1995018095-A1 | PROCESS FOR MAKING N-ACYL TAURIDES | FINETEX, INC. (US) | 1995-07-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12391772-B2 | Modified starches for home care and personal care | GALC, AMY2A, MGAM | CA1 386/4885CA2 501/4885CA9 115/4885 |
| US-20240043570-A1 | MODIFIED STARCHES FOR HOME CARE AND PERSONAL CARE | GALC, AMY2A, MGAM | CA1 386/4885CA2 501/4885CA9 115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.